To attend this session virtually, please click:

One tap mobile:

US: +16465588656,,98471212220# or +16469313860,,98471212220#

Meeting URL:

https://baystatehealth.zoom.us/j/98471212220?pwd=oO2ABSs52wFS2nXURfhlG8d1Awx9MC.1

Meeting ID:

984 7121 2220

Passcode:

065358

For questions, please contact Robert Ventulett via email at [email protected]. 

Objectives

After participating in this educational activity, attendees should be able to:
1| Define Interstitial Lung Disease (ILD).
2| Classify interstitial lung diseases into major categories.
3| Interpret key clinical, physiologic, and HRCT findings to differentiate common ILD patterns.
4| Formulate a stepwise diagnostic approach to suspected ILD.
5| Develop an evidence-based management plan for ILD.

Presenter(s): 

Mohammad Abu-Hishmeh, MD, MBA, FCCP
Assistant Professor of Medicine, UMass Chan Medical School-Baystate
Director of Interstitial Lung Disease Program
Program Director of Critical Care Fellowship Program
Division of Pulmonary and Critical Care Medicine, BMC

 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?

Mohammad Abu-Hishmen, MD, MBA, FCCP

 

Speaker/Author

 

No relevant relationships with ineligible companies to disclose

 

No

 

Session date: 
05/05/2026 - 12:00pm to 1:00pm EDT
Location: 
Webinar
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.